I thing there is still abit of an overhang of stock from the NXS holders who accepted the offer and now swtiching back into NXS.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025